1. Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.
- Author
-
Chitta KS, Paulus A, Ailawadhi S, Foster BA, Moser MT, Starostik P, Masood A, Sher T, Miller KC, Iancu DM, Conroy J, Nowak NJ, Sait SN, Personett DA, Coleman M, Furman RR, Martin P, Ansell SM, Lee K, and Chanan-Khan AA
- Subjects
- Animals, Base Sequence, Cytogenetic Analysis, Disease Models, Animal, Female, Humans, Immunoglobulin Heavy Chains chemistry, Immunoglobulin Heavy Chains genetics, Immunoglobulin M biosynthesis, Immunoglobulin M genetics, Immunoglobulin kappa-Chains genetics, Immunoglobulin kappa-Chains metabolism, Immunophenotyping, Mice, Middle Aged, Molecular Sequence Data, Mutation, Myeloid Differentiation Factor 88 genetics, Polymorphism, Single Nucleotide, Sequence Alignment, Transplantation, Heterologous, Waldenstrom Macroglobulinemia pathology, Cell Line, Tumor, Waldenstrom Macroglobulinemia genetics, Waldenstrom Macroglobulinemia metabolism
- Abstract
Understanding the biology of Waldenström macroglobulinemia is hindered by a lack of preclinical models. We report a novel cell line, RPCI-WM1, from a patient treated for WM. The cell line secretes human immunoglobulin M (h-IgM) with κ-light chain restriction identical to the primary tumor. The cell line has a modal chromosomal number of 46 and harbors chromosomal changes such as deletion of 6q21, monoallelic deletion of 9p21 (CDKN2A), 13q14 (RB1) and 18q21 (BCL-2), with a consistent amplification of 14q32 (immunoglobulin heavy chain; IgH) identical to its founding tumor sample. The clonal relationship is confirmed by identical CDR3 length and single nucleotide polymorphisms as well as a matching IgH sequence of the cell line and founding tumor. Both also harbor a heterozygous, non-synonymous mutation at amino acid 265 in the MYD88 gene (L265P). The cell line expresses most of the cell surface markers present on the parent cells. Overall, RPCI-WM1 represents a valuable model to study Waldenström macroglobulinemia.
- Published
- 2013
- Full Text
- View/download PDF